Recent highlights of metabolomics for Traditional Chinese Medicine

Pharmazie

Volumn 67, Issue 8, 2012, Pages 667-675

  Zhang, Aihua ^a   Sun, Hui ^a   Wang, Xijun ^a  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; BIOLOGICAL MARKER; PLANT EXTRACT;

BIOMEDICINE; CHINESE MEDICINE; DRUG SURVEILLANCE PROGRAM; HEALTH; HERBAL MEDICINE; MEDICAL RESEARCH; METABOLOME; METABOLOMICS; REVIEW;

ANIMALS; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; METABOLOMICS; RESEARCH;

EID: 84866132079     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2012.2511     Document Type: Review

References (101)

1. Arakaki AK, J Skolnick, JF McDonald (2008) Marker metabolites can be therapeutic targets as well. Nature 456: 443.
2. Adams M, Mahringer A, Kunert O, Fricker G, Efferth T, Bauer R (2007) Cytotoxicity and p-glycoprotein modulating effects of quinolones and indoloquinazolines from the Chinese herb Evodia rutaecarpa. Planta Med 73: 1554-1157.
3. Agnolet S, Jaroszewski JW, Verpoorte R, Staerk D (2010) NMR-based metabolomics combined with HPLC-PDA-MS- SPE-NMR for investigation of standardized Ginkgo biloba preparations. Metabolomics 6: 292-302.
4. Beckonert O, Coen M, Keun HC, Wang Y, Ebbels TM, Holmes E, Lindon JC, Nicholson JK (2010) High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues. Nat Protoc 25: 1019-1032.
5. Blow N (2008) Metabolomics: Biochemistry's new look. Nature 455: 697-700.
6. Bluestone JA, Herold K, Eisenbarth G (2010) Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464: 1293-1300.
7. Bian Q, Jia K, Liu SF, Shu B, Liang QQ, Zhou CJ, Zhou Q, Wang YJ (2011) Inhibitory effect of YQHYRJ recipe on osteoblast differentiation induced by BMP-2 in fibroblasts from posterior longitudinal ligament of mice. Pharmazie 66: 784-790.
8. Chen M, Su M, Zhao L, Jiang J, Liu P, Cheng J, Lai Y, Liu Y, Jia W (2006) Metabonomic study of aristolochic acid-induced nephrotoxicity in rats. J Proteome Res 5: 995-1002.
9. Chen M, Ni Y, Duan H, Qiu Y, Guo C, Jiao Y, Shi H, Su M, Jia W (2008) Mass spectrometry-based metabolic profiling of rat urine associated with general toxicity induced by the multiglycoside of Tripterygium wilfordii Hook. f. Chem Res Toxicol 21: 288-294.
10. Clayton TA, Lindon JC, Cloarec O, Antti H, Charuel C, Hanton G, Provost JP, Le Net JL, Baker D, Walley RJ, Everett JR, Nicholson JK (2006) Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 440: 1073-1077.
11. Cooks RG, Ouyang Z, Takats Z, Wiseman JM (2006) Detection technologies. Ambient mass spectrometry. Science 311: 1566-1570.
12. Dai H, Xiao C, Liu H, Hao F, Tang H (2010) Combined NMR and LC-DAD-MS analysis reveals comprehensive metabonomic variations for three phenotypic cultivars of Salvia Miltiorrhiza Bunge. J Proteome Res 9: 1565-1578.
13. Davies IW, Welch CJ (2009) Looking forward in pharmaceutical process chemistry. Science 325: 701-704.
14. Dharia NV, Chatterjee A, Winzeler EA (2010) Genomics and systems biology in malaria drug discovery. Curr Opin Investig Drugs 11:131-138.
15. de Bono JS, Ashworth A (2010) Translating cancer research into targeted therapeutics. Nature 467: 543-549.
16. Evason K, Huang C, Yamben I, Covey DF, Kornfeld K (2005) Anticonvulsant medications extend worm life-span. Science 307: 258-262.
17. Fidock DA (2010) Drug discovery: Priming the antimalarial pipeline. Nature 465: 297-298.
18. Fiehn O (2002) Metabolomics-the link between genotypes and phenotypes. Plant Mol Biol 48: 155-171.
19. Fischer HP (2005) Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery. Biotechnol Annu Rev 11: 1-68.
20. Fitzgerald G (2010) Drug development needs a newbrand of science. Nature 468: 869.
21. Holmes E, Loo RL, Stamler J, Bictash M, Yap IK, Chan Q, Ebbels T, De Iorio M, Brown IJ, Veselkov KA, Daviglus ML, Kesteloot H, Ueshima H, Zhao L, Nicholson JK, Elliott P (2008) Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 453: 396-401.
22. Gallagher WM, Tweats D, Koenig J (2009) Omic profiling for drug safety assessment: current trends and public-private partnerships. Drug Discov Today 14: 337-342.
23. Giri S, Idle JR, Chen C, Zabriskie TM, Krausz KW, Gonzalez FJ (2006) A metabolomic approach to the metabolism of the areca nut alkaloids arecoline and arecaidine in the mouse. Chem Res Toxicol 19: 818-827.
24. Greensfelder L (2000) Alternative medicine. Herbal product linked to cancer. Science 288: 1946.
25. Griffiths WJ, Koal T, Wang Y, Kohl M, Enot DP, Deigner HP (2010) Targeted metabolomics for biomarker discovery. Angew Chem Int Ed Engl 49: 5426-5445.
26. Godzien J, Ciborowski M, Angulo S, Ruperez FJ, Paz Martínez M, Señorans FJ, Cifuentes A, Ibañez E, Barbas C (2011) Metabolomic approach with LC-QTOF to study the effect of a nutraceutical treatment on urine of diabetic rats. J Proteome Res 10: 837-844.
27. Gu Y, Zhang Y, Shi X, Li X, Hong J, Chen J, Gu W, Lu X, Xu G, Ning G (2010) Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics. Talanta 81: 766-772.
28. Hood L, Heath JR, Phelps ME, Lin B (2004) Systems biology and new technologies enable predictive and preventative medicine. Science 306: 640-643.
29. Huang JH, Shen ZY, Wu B (2008) Effect and mechanism of Epimedium flavanoids for aging retardation from viewpoint of transcriptomics and metabonomics. Zhongguo Zhong Xi Yi Jie He Za Zhi 28: 47-50.
30. Huang L, Zhao H, Huang B, Zheng C, Peng W, Qin L (2011) Acanthopanax senticosus: review of botany, chemistry and pharmacology. Pharmazie. 66: 83-97.
31. Jacob SS, Smith NW, Legido-Quigley C (2007) Assessment of Chinese medicinal herb metabolite profiles by UPLC-MS- based methodology for the detection of aristolochic acids. J Sep Sci 30: 1200-1206.
32. Ji H, Ehrlich LI, Seita J, Murakami P, Doi A, Lindau P, Lee H, Aryee MJ, Irizarry RA, Kim K, Rossi DJ, Inlay MA, Serwold T, Karsunky H, Ho L, Daley GQ, Weissman IL, Feinberg AP (2010) Comprehensive methylome map of lineage commitment from haematopoietic progenitors. Nature 467: 338-342.
33. Kaiser J (2010) National Institutes of Health. A government niche for translational medicine and drug development. Science 330: 1462-1463.
34. Kang J, Lee S, Kang S, Kwon HN, Park JH, Kwon SW, Park S (2008) NMR-based metabolomics approach for the differentiation of ginseng (Panax ginseng) roots from different origins. Arch Pharm Res 31: 330-336.
35. Kell DB (2006) Systems biology, metabolic modelling and metabolomics in drug discovery and development. Drug Discov Today 11: 1085-1092.
36. Keun HC, Athersuch TJ (2007) Application of metabonomics in drug development. Pharmacogenomics 8: 731-741.
37. Klayman DL (1985) Qinghaosu (artemisinin): an antimalarial drug from China. Science 228: 1049-1055.
38. Koul A, Arnoult E, Lounis N, Guillemont J, Andries K (2011) The challenge of new drug discovery for tuberculosis. Nature 469: 483-490.
39. Kotłowska A, Sworczak K, Stepnowski P (2011) Urine metabolomics analysis for adrenal incidentaloma activity detection and biomarker discovery. J Chromatogr B Analyt Technol Biomed Life Sci 879: 359-363.
40. Law WS, Huang PY, Ong ES, Ong CN, Li SF, Pasikanti KK, Chan EC (2008) Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy. Rapid Commun Mass Spectrom 22: 2436-2446.
41. Lee SY, Kim HU, Park JH, Park JM, Kim TY (2009) Metabolic engineering of microorganisms: general strategies and drug production. Drug Discov Today 14: 78-88.
42. Lee W, Jiang Z, Liu J, Haverty PM, Guan Y, Stinson J, Yue P, Zhang Y, Pant KP, Bhatt D, Ha C, Johnson S, Kennemer MI, Mohan S, Nazarenko I, Watanabe C, Sparks AB, Shames DS, Gentleman R, de Sauvage FJ, Stern H, Pandita A, Ballinger DG, Drmanac R, Modrusan Z, Seshagiri S, Zhang Z (2010) The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 465: 473-477.
43. Li F, Lu X, Liu H, Liu M, Xiong Z (2007) A pharmaco-metabonomic study on the therapeutic basis and metabolic effects of Epimedium brevicornum Maxim on hydrocortisone-induced rat using UPLC-MS. Biomed Chromatogr 21: 397-405.
44. Li L, Sun B, Zhang Q, Fang J, Ma K, Li Y, Chen H, Dong F, Gao Y, Li F, Yan X (2008) Metabonomic study on the toxicity of Hei-Shun-Pian, the processed lateral root of Aconitum carmichaelii Debx. (Ranunculaceae). J Ethnopharmacol 116: 561-568.
45. Li JW, Vederas JC (2009) Drug discovery and natural products: end of an era or an endless frontier? Science 325: 161-165.
46. Liang Q, Ni C, Xie M, Zhang Q, Zhang YX, Yan XZ, Yang MJ, Peng SQ, Zhang YZ (2009) Nephrotoxicity study of Aristolochia fangchi in rats by metabonomics. Zhong Xi Yi Jie He Xue Bao 7: 746-752.
47. Liang Y, Kang A, Xie T, Zheng X, Dai C, Hao H, A J, Sheng L, Xie L, Wang GJ (2010) Influence of segmental and selected ion monitoring on quantitation of multi-component using high-pressure liquid chromatography-quadrupole mass spectrometry: Simultaneous detection of 16 saponins in rat plasma as a case. J Chromatogr A 1217: 4501-4506.
48. Lindon JC, Holmes E, Bollard ME, Stanley EG, Nicholson JK (2004) Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers 9: 1-31.
49. Lindon JC, Holmes E, Nicholson JK (2007) Metabonomics in pharmaceutical R&D. FEBS J 274: 1140-1151.
50. Liu NQ, Cao M, Frédérich M, Choi YH, Verpoorte R, van der Kooy F (2010) Metabolomic investigation of the ethnopharmacological use of Artemisia afra with NMR spectroscopy and multivariate data analysis. J Ethnopharmacol 128: 230-235.
51. Liu Y, Huang R, Liu L, Peng J, Xiao B, Yang J, Miao Z, Huang H (2010) Metabonomics study of urine from Sprague-Dawley rats exposed to Huang-yao-zi using (1)H NMR spectroscopy. J Pharm Biomed Anal 52: 136-141.
52. Lv Y, Liu X, Yan S, Liang X, Yang Y, Dai W, Zhang W (2010) Metabolomic study of myocardial ischemia and intervention effects of compound Danshen tablets in rats using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. J Pharm Biomed Anal 52: 129-135.
53. Manna SK, Patterson AD, Yang Q, Krausz KW, Li H, Idle JR, Fornace AJ Jr, Gonzalez FJ (2010) Identification of noninvasive biomarkers for alcohol-induced liver disease using urinary metabolomics and the Pparanull mouse. J Proteome Res 9: 4176-4188.
54. Mazzone M, Carmeliet P (2008) Drug discovery: a lifeline for suffocating tissues. Nature 453: 1194-1195.
55. Nicholson JK, Wilson ID (2003) Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov 2: 668-676.
56. Nicholson JK, Lindon JC (2008) Systems biology: Metabonomics. Nature 455: 1054-1056.
57. Normile D (2003) Asian medicine, the new face of traditional Chinese medicine. Science 299: 188-190.
58. Park AJ (2002) What's in a Name? A systematic review of the nomenclature of Chinese medical formulae. J Chin Med 30: 419-427.
59. Prestele J, Hierl G, Scherling C, Hetkamp S, Schwechheimer C, Isono E, Weckwerth W, Wanner G, Gietl C (2010) Different functions of the C3HC4 zinc RING finger peroxins PEX10, PEX2, and PEX12 in peroxisome formation and matrix protein import. Proc Natl Acad Sci U S A 107: 14915-14920.
60. Schrattenholz A, Soskić V (2008) What does systems biology mean for drug development? Curr Med Chem 15: 1520-1528.
61. Shaham O, Slate NG, Goldberger O, Xu Q, Ramanathan A, Souza AL, Clish CB, Sims KB, Mootha VK (2010) A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells. Proc Natl Acad Sci U S A 107: 1571-1575.
62. Shroff R, Rulísek L, Doubsky J, Svatos A (2009) Acid-base-driven matrix-assisted mass spectrometry for targeted metabolomics. Proc Natl Acad Sci U S A 106: 10092-10096.
63. Shyur LF, Yang NS (2008) Metabolomics for phytomedicine research and drug development. Curr Opin Chem Biol 12: 66-71.
64. Smith SB, Qu HQ, Taleb N, Kishimoto NY, Scheel DW, Lu Y, Patch AM, Grabs R, Wang J, Lynn FC, Miyatsuka T, Mitchell J, Seerke R, Désir J, Eijnden SV, Abramowicz M, Kacet N, Weill J, Renard ME, Gentile M, Hansen I, Dewar K, Hattersley AT, Wang R, Wilson ME, Johnson JD, Polychronakos C, German MS (2010) Rfx6 directs islet formation and insulin production in mice and humans. Nature 463: 775-780.
65. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM (2009) Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457: 910-914.
66. Song HT, Zhang Q, Wang HJ, Guo XJ, Chen DW, He ZG (2007) Preparation of the traditional Chinese medicine compound recipe Shuxiong sustained-release capsules by multiparticulate time-controlled explosion technology. Pharmazie 62: 372-377.
67. Stone R (2008) Biochemistry. Lifting the veil on traditional Chinese medicine. Science 319: 709-710.
68. Sun B, Li L, Wu S, Zhang Q, Li H, Chen H, Li F, Dong F, Yan X (2009) Metabolomic analysis of biofluids from rats treated with Aconitum alkaloids using nuclear magnetic resonance and gas chromatography/time-of-flight mass spectrometry. Anal Biochem 395: 125-133.
69. Sun B, Wu S, Li L, Li H, Zhang Q, Chen H, Li F, Dong F, Yan X (2009) A metabolomic analysis of the toxicity of Aconitum sp. alkaloids in rats using gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom 23: 1221-1228.
70. Tolstikov VV, Fiehn O, Tanaka N (2007) Application of liquid chromatography-mass spectrometry analysis in metabolomics: reversed-phase monolithic capillary chromatography and hydrophilic chromatography coupled to electrospray ionization-mass spectrometry. Methods Mol Biol 358: 141-155.
71. Van Dorsten FA, Daykin CA, Mulder TP, Van Duynhoven JP (2006) Metabonomics approach to determine metabolic differences between green tea and black tea consumption. J Agric Food Chem 54: 6929-6938.
72. van der Greef J, Martin S, Juhasz P, Adourian A, Plasterer T, Verheij ER, McBurney RN (2007) The art and practice of systems biology in medicine: mapping patterns of relationships. J Proteome Res 6: 1540-1559.
73. Vlietinck A, Pieters L, Apers S (2009) Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union. Planta Med 75: 683-688.
74. Wang M, Lamers RJ, Korthout HA, van Nesselrooij JH, Witkamp RF, van der Heijden R, Voshol PJ, Havekes LM, Verpoorte R, van der Greef J(2005) Metabolomics in the context of systems biology: bridging traditional Chinese medicine and molecular pharmacology. Phytother Res 19:173-182.
75. Walgren JL, Thompson DC (2004) Application of proteomic technologies in the drug development process. Toxicol Lett 149: 377-385.
76. Watkins SM, German JB (2002) Metabolomics and biochemical profiling in drug discovery and development. Curr Opin Mol Ther 4: 224-228.
77. Wang Y, Wang J, Yao M, Zhao X, Fritsche J, Schmitt-Kopplin P, Cai Z, Wan D, Lu X, Yang S, Gu J, Häring HU, Schleicher ED, Lehmann R, Xu G (2008) Metabonomics study on the effects of the ginsenoside Rg3 in a beta- cyclodextrin-based formulation on tumor-bearing rats by a fully automatic hydrophilic interaction/reversed-phase column-switching HPLC-ESI-MS approach. Anal Chem 80: 4680-4688.
78. Wang H, Ma C, Ma L, Du Z, Wang H, Ye H, Li G, Liu B, Xu G (2009) Secondary metabolic profiling and artemisinin biosynthesis of two genotypes of Artemisia annua. Planta Med 75: 1625-1633.
79. Wang L, Zhou GB, Liu P, Song JH, Liang Y, Yan XJ, Xu F, Wang BS, Mao JH, Shen ZX, Chen SJ, Chen Z (2008a) Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci U S A 105: 4826-4831.
80. Wang X, Lv H, Sun H, Liu L, Yang B, Sun W, Wang P, Zhou D, Zhao L, Dou S, Zhang G, Cao H (2008b) Metabolic urinary profiling of alcohol hepatotoxicity and intervention effects of Yin Chen Hao Tang in rats using ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry. J Pharm Biomed Anal 48: 1161-1168.
81. Wang P, Sun H, Lv H, Sun W, Yuan Y, Han Y, Wang D, Zhang A, Wang X (2010a) Thyroxine and reserpine-induced changes in metabolic profiles of rat urine and the therapeutic effect of Liu Wei Di Huang Wan detected by UPLC-HDMS. J Pharm Biomed Anal 53: 631-645.
82. Wang M, Rang W, Zhang Q, Huo C, Ma Z, Wang Y, Yan X, Gao Y (2010b) NMR-spectroscopy-based metabonomic approach to analysis of Siwutang, a novel prescription, treated blood deficiency in mice. Zhongguo Zhong Yao Za Zhi 35: 630-634.
83. Wang X, Sun H, Zhang A, Sun W, Wang P, Wang Z (2011) Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: As pillars of the bridge between Chinese and Western medicine. J Pharm Biomed Anal 25: 173-182.
84. Wishart DS (2008) Applications of metabolomics in drug discovery and development. Drugs R D 9: 307-322.
85. Wu B, Yan S, Lin Z, Wang Q, Yang Y, Yang G, Shen Z, Zhang W (2008) Metabonomic study on ageing: NMR-based investigation into rat urinary metabolites and the effect of the total flavone of Epimedium. Mol Biosyst 4: 855-861.
86. Xiao C, Dai H, Liu H, Wang Y, Tang H (2008) Revealing the metabonomic variation of rosemary extracts using 1H NMR spectroscopy and multivariate data analysis. J Agric Food Chem 56: 10142-10153.
87. Xie G, Plumb R, Su M, Xu Z, Zhao A, Qiu M, Long X, Liu Z, Jia W (2008) Ultra-performance LC/TOF MS analysis of medicinal Panax herbs for metabolomic research. J Sep Sci 31: 1015-1026.
88. Xie B, Gong T, Gao R, Liu J, Zuo J, Wang X, Zhang Z (2009) Development of rat urinary HPLC-UV profiling for metabonomic study on Liuwei Dihuang Pills. J Pharm Biomed Anal 49: 492-497.
89. Xu EY, Schaefer WH, Xu Q (2009) Metabolomics in pharmaceutical research and development: metabolites, mechanisms and pathways. Curr Opin Drug Discov Devel 12: 40-52.
90. Xu G, Ma X, Zhang Q, Li B, Huang L, Yu R, Liu H (2009) Study of metabonomics on pharmacological action appraisal Rhizoma coptidis in rats. Zhongguo Zhong Yao Za Zhi 34: 1845-1847.
91. Xue T, Roy R (2003) Studying traditional Chinese medicine. Science 300: 740-741.
92. Yan S, Wu B, Lin Z, Jin H, Huang J, Yang Y, Zhang X, Shen Z, Zhang W (2010) Metabonomic characterization of aging and investigation on the anti-aging effects of total flavones of Epimedium. Mol Biosyst 5: 1204-1213.
93. Yi LZ, Yuan DL, Liang YZ, Xie PS, Zhao Y (2009) Fingerprinting alterations of secondary metabolites of tangerine peels during growth by HPLC-DAD and chemometric methods. Anal Chim Acta 649: 43-51.
94. Yuliana ND, Khatib A, Choi YH, Verpoorte R (2011) Metabolomics for bioactivity assessment of natural products. Phytother Res 25: 157-169.
95. Zhang QY, Mao JH, Liu P, Huang QH, Lu J, Xie YY, Weng L, Zhang Y, Chen Q, Chen SJ, Chen Z (2009a) A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL-associated leukemia. Proc Natl Acad Sci U S A 106: 3378-3383.
96. Zhang Q, Wang GJ, A JY, Wu D, Zhu LL, Ma B, Du Y (2009b) Application of GC/MS-based metabonomic profiling in studying the lipid-regulating effects of Ginkgo biloba extract on diet-induced hyperlipidemia in rats. Acta Pharmacol Sin 30: 1674-1687.
97. Zhang A, Sun H, Wang Z, Sun W, Wang P, Wang X (2010a) Metabolomics: towards understanding traditional Chinese medicine. Planta Med 76: 2026-2035.
98. Zhang Q, Xu G, Wu L, Ma X, Zeng Z, Huang L, Yu R, Liu H (2010b) Preliminary study of metabonomcs on aqueous extract of Evodia rutaecarpa in sprague-dawley rats. Zhongguo Zhong Yao Za Zhi 35: 99-102.
99. Zhang A, Sun H, Wang P, Han Y, Wang X (2012) Modern analytical techniques in metabolomics analysis. Analyst 137: 293-300.
100. Zhao X, Zhang Y, Meng X, Yin P, Deng C, Chen J, Wang Z, Xu G (2008) Effect of a traditional Chinese medicine preparation Xindi soft capsule on rat model of acute blood stasis: a urinary metabonomics study based on liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 873: 151-158.
101. Zhang Y, Li PP (2011) Assessment of shikonin for potential estrogenic activity by dual-luciferase reporter based bioluminescent measurements in vitro. Pharmazie 66: 141-143.